More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]
Adobe Class Action
Data Breach and Privacy, Existing Cases
On April 3, 2025, Lowey filed a data privacy class action against Adobe, Inc. alleging it used consumers’ personally identifiable information and online activity to create user profiles without obtaining […]
UCSF Class Action
Data Breach and Privacy, Existing Cases
In Doe v. The Regents of the University of California, No. 3:23-cv-00598 (N.D. Cal.), Lowey Dannenberg represents a class of individuals who used the University of California San Francisco Medical […]
News
SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Files Securities Class Action Lawsuit Against Arrival SA. on Behalf of Investors Who Acquired Shares from November 18, 2020 and November 19, 2021, Inclusive, and Encourages Investors to Inquire About the Lead Plaintiff Position Before the February 22, 2022 Lead Plaintiff Deadline
NEW YORK, Feb 14, 2022 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, has filed a federal securities class action in the United States District Court Southern District of New York on behalf of its...
Blog
Rule 10b5-1 Trading Plans Under Scrutiny: Are They Subject To Insider Trading Abuse?
The U.S. Securities and Exchange Commission (SEC) is working to overhaul the rule that protects corporate executives from insider trading accusations when they buy or sell their company’s stocks. Executives are regularly exposed to material nonpublic information (MNPI) and would be at risk of...

